Other
Richter's Transformation
0
Pipeline Programs↗
5
Active Trials↗
3
Companies Involved↗
Richter's Transformation is an early-stage landscape with 0 programs across 3 companies. The most active players are Karyopharm Therapeutics Inc, TG Therapeutics, Inc., Ono Pharmaceutical Co. Ltd.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
9
clinical trials
Recruiting5 · 56%
Terminated3 · 33%
Completed1 · 11%
Clinical Trials
Trial Activity
9 trials
Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation
Recruiting·—·Phase 2·NCT05672173·20 enrolled
Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation
Recruiting·—·Phase 1·NCT06735664·23 enrolled
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Recruiting·—·Phase 2·NCT06043674·70 enrolled
PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)
Terminated·—·Phase 2·NCT02378038·5 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)